AR067110A1 - Composicion farmaceutica combinada - Google Patents

Composicion farmaceutica combinada

Info

Publication number
AR067110A1
AR067110A1 ARP080102666A ARP080102666A AR067110A1 AR 067110 A1 AR067110 A1 AR 067110A1 AR P080102666 A ARP080102666 A AR P080102666A AR P080102666 A ARP080102666 A AR P080102666A AR 067110 A1 AR067110 A1 AR 067110A1
Authority
AR
Argentina
Prior art keywords
cover
pharmaceutical composition
polymer
plasticizer
antioxidant
Prior art date
Application number
ARP080102666A
Other languages
English (en)
Inventor
Portocarrero Jose Eduardo Santillana
Paniagua Angelica Arzola
Ramirez Martha Keyla Corona
Original Assignee
Senosiain S A De C V Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40228222&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR067110(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Senosiain S A De C V Lab filed Critical Senosiain S A De C V Lab
Publication of AR067110A1 publication Critical patent/AR067110A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Composicion farmacéutica en cápsulas con microesferas recubiertas que comprende la combinacion de besilato de amlodipino y pravastatina sodica y sus sales farmacéuticamente aceptables, adicionalmente vehículos o excipientes farmacéuticamente aceptables; así como a un proceso para la fabricacion de la composicion y al uso de dicha combinacion para la preparacion de un medicamento con actividad terapéutica sinérgica indicado en el tratamiento de padecimientos cardiovasculares del tipo de hipertension arterial y dislipidemia y su comorbilidad. Reivindicacion 3: La composicion .farmacéutica de la reivindicacion 2 caracterizada: porque las microesferas recubiertas comprenden: Nucleos inertes; a) Cubierta uno, que incluye al principio activo uno, al menos un antioxidante, al menos un plastificante, al menos un amortiguador, y al menos un polímero adhesivo ligante aglutinante; b) Cubierta aislante que incluye, al menos un polímero en solucion acuosa; c) Cubierta que incluye al principio activo dos, al menos un antioxidante, al menos un plastificante, al menos un amortiguador, y al menos un polímero adhesivo ligante aglutinante; y d) Cubierta protectora de recubrimiento, que incluye al menos un polímero de recubrimiento y al menos un excipiente.
ARP080102666A 2007-07-11 2008-06-20 Composicion farmaceutica combinada AR067110A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2007008440A MX2007008440A (es) 2007-07-11 2007-07-11 Composicion farmaceutica combinada.

Publications (1)

Publication Number Publication Date
AR067110A1 true AR067110A1 (es) 2009-09-30

Family

ID=40228222

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080102666A AR067110A1 (es) 2007-07-11 2008-06-20 Composicion farmaceutica combinada

Country Status (7)

Country Link
AR (1) AR067110A1 (es)
CL (1) CL2008001895A1 (es)
MX (1) MX2007008440A (es)
PA (1) PA8785701A1 (es)
PE (1) PE20090439A1 (es)
UY (1) UY31153A1 (es)
WO (1) WO2009007808A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101804055B (zh) * 2010-04-27 2012-01-25 施慧达药业集团(吉林)有限公司 复方药物制剂
MX351059B (es) * 2012-08-17 2017-09-29 Laboratorios Senosiain S A De C V Star Composicion farmaceutica oral en forma de microesferas y proceso de elaboracion.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU2700A (sh) * 1997-08-29 2002-06-19 Pfizer Products Inc. Farmaceutska kombinacija koja obuhvata amlodipin i statin jedinjenja
WO2002017913A1 (fr) * 2000-08-30 2002-03-07 Sankyo Company, Limited Compositions medicinales utilisees dans la prevention ou le traitement de l'insuffisance cardiaque

Also Published As

Publication number Publication date
CL2008001895A1 (es) 2008-08-22
WO2009007808A1 (es) 2009-01-15
UY31153A1 (es) 2009-03-02
PE20090439A1 (es) 2009-05-24
MX2007008440A (es) 2009-02-18
WO2009007808A4 (es) 2009-03-05
PA8785701A1 (es) 2009-04-23

Similar Documents

Publication Publication Date Title
BR112018015273A2 (pt) derivados de benzimidazol como moduladores de ror-gama
ECSP12011838A (es) Derivados de la cromenona con actividad anti-tumoral
CL2011003266A1 (es) Compuestos derivados de imidazolidin-2-ona, con actividad inhibidora de 17alfa-hidroxilasa/liasa-c17,20; composicion farmaceutica que los comprende; y uso en el tratamiento de inflamacion o cancer, entre otras.
CR20170563A (es) Compuestos de benzoxacepina oxazolidinona y métodos de uso.
DOP2010000011A (es) Derivados de pirimidina trisustituida para el tratamiento de enfermedades proliferativas
BR112016010383A2 (pt) compostos de pyy seletivos e usos dos mesmos
DK2324008T3 (da) Diarylpyrazol som protein kinase inhibitorer
GT200600096A (es) Composicion farmaceutica para el tratamiento del cancer
WO2012142511A3 (en) Orthomolecular compositions and their use in stabilizing the extracellular matrix
BR112015018087A8 (pt) composto, composição farmacêutica e uso
CO6251364A2 (es) Derivados de morfolino pirimidina utilazdos en enfermedades relacionados con mtor quinasa y/o p13k
ECSP109934A (es) Compuesto - 946
BR112015030315A2 (pt) derivado de 4-alquinilimidazol e medicamento compreendendo o mesmo como ingrediente ativo
CO6491060A2 (es) Compuestos y composiciones para el tratamiento de enfermedades parasitarias
UY33183A (es) Compuestos inhibidores de virus flaviviridae, composición farmaceutica que los contiene y su uso en la manufactura de un medicamento
CL2015002608A1 (es) Compuesto de amino-pirazol y usos medicinales relacionados.
BR112015027114A2 (pt) novos compostos para os inibidores seletivos de histona desacetilase, e composição farmacêutica compreendendo os mesmos
BRPI0517792A (pt) macrolonas - quinolonas amino-substituìdas
CR20180184A (es) Compuestos heteroarilo y su uso como fármacos terapéuticos
CR20140144A (es) Derivados de estra-1,3,5 (10), 16-tetraen-3-carboxamida, procedimientos para su preparación, preparados farmacéuticos que los contienen, así como su uso para la preparación de medicamentos
BR112014018795A2 (pt) derivados de 1h-pirrolo[2,3-b]piridina e seu uso como inibidores de cinase
CL2007000781A1 (es) Nanoparticulas que comprenden un inhibidor de quinasa de tirosina receptora del factor de crecimiento derivado de plaquetas; proceso de preparacion; composicion farmaceutica; y uso para el tratamiento de enfermedades vasculares, tales como restenosis
BR112015023356A2 (pt) inibidores de quinase pirrol[2,3-b]piridina cdk9
CR20110704A (es) Composiciones de dosis fija farmacéuticas sólidas que comprenden irbesartán y amilodipina, su preparación y su aplicación terapéutica
BRPI0606140A2 (pt) tiazolidinonas, preparação e uso das mesmas como medicamento

Legal Events

Date Code Title Description
FB Suspension of granting procedure